US stocks fell in choppy trade and the Nasdaq slid to a fresh 6 and 1/2-year low on Monday as shares of the biggest drugmakers fell after Mercks proposed a $41 billion take-over of Schering-Plough. Large mergers and acquisitions are generally viewed as a show of support for equity valuations.
0 comments
Post a Comment